Aminoferrocene-Based Prodrugs and Their Effects on Human Normal and Cancer Cells as Well as Bacterial Cells
摘要:
Aminoferrocene-based prodrugs are activated under cancer-specific conditions (high concentration of reactive oxygen species, ROS) with the formation of glutathione scavengers (p-quinone methide) and ROS-generating iron complexes. Herein, we explored three structural modifications of these prodrugs in an attempt to improve their properties: (a) the attachment of a -COOH function to the ferrocene fragment leads to the improvement of water solubility and reactivity in vitro but also decreases cell-membrane permeability and biological activity, (b) the alkylation of the N-benzyl residue does not show any significant affect, and (c) the attachment of the second arylboronic acid fragment improves the toxicity (IC50) of the prodrugs toward human promyelocytic leukemia cells (HL-60) from 52 to 12 mu M. Finally, we demonstrated that the prodrugs are active against primary chronic lymphocytic leukemia (CLL) cells, with the, best compounds exhibiting an IC50 value of 1.5 mu M. The most active compounds were found to not affect mononuclear cells and representative bacterial cells.
The preparation of a new type of ferrocene-based compounds with large conjugated system containing symmetrical aromatic vinyl with Schiff base moieties and the study of their third-order nonlinear optical properties
作者:Weiguo Yu、Jianhong Jia、Jianrong Gao、Liang Han、Yujin Li
DOI:10.1016/j.cplett.2016.04.096
日期:2016.9
Herein we reported the preparation of a new type of ferrocene-based compounds with large conjugated system containing symmetrical aromatic vinyl and Schiff base moieties and the study of their third-order nonlinear optical (NLO) properties. Their third-order NLO properties were measured using femtosecond laser and degenerate four-wave mixing (DFWM) technique. The obtained χ (3) , n 2 and γ values of these
Sialic acid derivatives of the formula (I)
in which the symbols have the definitions stated in the description are suitable as medicaments, more particularly for diseases whose course is influenced by Siglec ligands.
A new ferrocene-based bulky pyridine as an efficient reusable homogeneous catalyst
作者:Bishwapran Kashyap、Prodeep Phukan
DOI:10.1039/c3ra41674g
日期:——
An effective approach to reusing a homogeneous catalyst has been demonstrated. A ferrocene-based bulky pyridine has been synthesized and utilized as a homogeneous catalyst for the synthesis of benzoylfumarates as well as for acetylation. After the reaction, the catalyst was separated by simple precipitation and reused without appreciable loss of activity.
Novel O-ferrocenoyl hydroxyproline conjugates: Synthesis, characterization and catalytic properties
作者:Lo’ay A. Al-Momani、Anas Lataifeh
DOI:10.1016/j.ica.2012.07.015
日期:2013.1
protected by tert-butloxycarbonyl (Boc) group at the N-terminus. The Boc removal of the ferrocene (Fc) hydroxy-L-proline conjugates affords a series of mono- and disubstituted Fc conjugates containing free amine at the N-terminus. These conjugates are characterized by NMR and IR spectroscopies as well as mass (MS) spectrometry. The catalytic properties of the free amine Fc conjugates toward aldol addition
[EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS D'IMMUNODÉFICIENCE HUMAINE
申请人:VIIV HEALTHCARE (NO 5) LTD
公开号:WO2016172425A1
公开(公告)日:2016-10-27
Compounds of Formulas I-VI, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth. Formula I is exemplified below: Formula (i)